跳至主要内容
临床试验/NCT00421668
NCT00421668已完成3 期

A Trial of Zinc and Micronutrients in Tanzanian Children

Harvard School of Public Health (HSPH)1 个研究点 分布在 1 个国家目标入组 2,400 人开始时间: 2007年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,400
试验地点
1
主要终点
Incidence of diarrhea

研究概览

简要总结

A randomized clinical trial of multiple micronutrients, zinc, zinc + micronutrients, or placebo among 2400 children born to HIV-negative Tanzanian mothers.

详细描述

We propose to study the efficacy of zinc or multiple micronutrient supplementation in reducing the risk of infectious diseases and growth faltering among infants and young children in Tanzania. Infants born to HIV-negative women will be recruited and randomly assigned in a factorial design to either zinc, micronutrients (vitamins C, E, B1, B2, niacin, B6, folate and B12), micronutrients plus zinc, or a placebo given daily. Children will be followed at monthly clinic visits from age 6 weeks for 18 months. Data obtained will include socioeconomic status, anthropometric data (weight, length, head circumference, and arm anthropometrics), dietary intake (including breastfeeding duration and frequency), hemoglobin, ferritin, and blood smear for malaria. The primary outcomes will be the incidence of diarrhea and respiratory tract infections. Secondary outcomes will be weight and length gain. A subset of children will be tested for blood concentrations of vitamin A, E, zinc and C-reactive protein. All children will receive a large periodic dose of vitamin A every 6 months as per standard of care in Tanzania.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Weeks 至 18 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Singleton, live born infants born to HIV- negative women
  • Mothers will need to have registered for pre-natal care before 34 weeks gestation
  • intend to stay in Dar es Salaam for until delivery and 18 months thereafter.

排除标准

  • infants born with multiple congenital abnormalities

研究组 & 干预措施

Multivitamins

Experimental

Vitamins C, E, B1, B2, niacin, B6, folate, and B12

干预措施: Multivitamins (Drug)

Multivitamins + Zinc

Experimental

Vitamins C, E, B1, B2, niacin, B6, folate and B12, and zinc

干预措施: Zinc (Drug)

Multivitamins + Zinc

Experimental

Vitamins C, E, B1, B2, niacin, B6, folate and B12, and zinc

干预措施: Multivitamins (Drug)

Zinc

Experimental

zinc

干预措施: Zinc (Drug)

Placebo

Placebo Comparator

placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Incidence of diarrhea

时间窗: from ages 6 weeks to 18 months

respiratory tract infections

时间窗: from ages 6 weeks to 18 months

次要结局

  • Weight gain(from age 6 weeks to 18 months)
  • Length/height gain(from age 6 weeks to 18 months)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Duggan

Professor of Nutrition

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验